These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9093953)

  • 1. Evaluation of a significantly shorter version of the Farnsworth-Munsell 100-hue test in patients with three different optic neuropathies.
    Nichols BE; Thompson HS; Stone EM
    J Neuroophthalmol; 1997 Mar; 17(1):1-6. PubMed ID: 9093953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing a new computer-based test for the clinical evaluation of color discrimination.
    Melamud A; Simpson E; Traboulsi EI
    Am J Ophthalmol; 2006 Dec; 142(6):953-60. PubMed ID: 17157581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of colored metameric equations to the diagnosis of optic neuropathies].
    Roth A; Hermès D; Pelizzone M; Borot N
    Ophtalmologie; 1987; 1(1):21-5. PubMed ID: 3153811
    [No Abstract]   [Full Text] [Related]  

  • 5. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
    Gregori B; Papazachariadis O; Farruggia A; Accornero N
    J Neurol Sci; 2011 Jan; 300(1-2):130-4. PubMed ID: 20875905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between visual acuity and color vision as an indicator of the cause of visual loss.
    Almog Y; Nemet A
    Am J Ophthalmol; 2010 Jun; 149(6):1000-4. PubMed ID: 20378093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.
    Liao SL; Chang TC; Lin LL
    Am J Ophthalmol; 2006 May; 141(5):810-818. PubMed ID: 16527228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.
    Thyagarajan S; Moradi P; Membrey L; Alistair D; Laidlaw H
    Ophthalmic Physiol Opt; 2007 May; 27(3):315-9. PubMed ID: 17470246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired color vision defects in retrobulbar neuritis.
    Griffin JF; Wray SH
    Am J Ophthalmol; 1978 Aug; 86(2):193-201. PubMed ID: 686121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pratical remarks on Farnsworth 100 Hue in acquired dyschromatopsies].
    Biais B; Guile Y
    Arch Ophtalmol (Paris); 1976 Feb; 36(2):147-54. PubMed ID: 132919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Color vision defects in optic neuropathies. Clinical forms].
    Lanthony P
    Ophtalmologie; 1987; 1(1):27-30. PubMed ID: 3153812
    [No Abstract]   [Full Text] [Related]  

  • 12. Color vision in dominant optic atrophy.
    Mäntyjärvi MI; Nerdrum K; Tuppurainen K
    J Clin Neuroophthalmol; 1992 Jun; 12(2):98-103. PubMed ID: 1629378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on color vision defects associated with optic nerve diseases by Farnsworth-Munsell 100 hue test. II. Comparison with liminal and supraliminal contrast sensitivity functions].
    Kazusa R
    Nippon Ganka Gakkai Zasshi; 1983; 87(12):1442-7. PubMed ID: 6608865
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of colour difference vectors in diagnosing congenital colour vision deficiencies with the Farnsworth-Munsell 100-hue test.
    Vingrys AJ; Atchison DA; Bowman KJ
    Ophthalmic Physiol Opt; 1992 Jan; 12(1):38-45. PubMed ID: 1584615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acquired colour defects by F.M. 100 Hue test.
    Sharma RG; Mishra YC; Verma GL; Goswami U
    Indian J Ophthalmol; 1982 Jul; 30(4):371-3. PubMed ID: 6984695
    [No Abstract]   [Full Text] [Related]  

  • 16. End-box scoring artefact evaluation of the Farnsworth-Munsell 100-Hue colour vision test.
    Viliūnas V; Lukauskiene R; Svegzda A; Zukauskas A
    Ophthalmic Physiol Opt; 2006 Nov; 26(6):580-6. PubMed ID: 17040422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Farnsworth-Munsell 100 hue test and optic neuritis.
    Hoyt CS
    Br J Ophthalmol; 1993 Feb; 77(2):65. PubMed ID: 8435419
    [No Abstract]   [Full Text] [Related]  

  • 18. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of color perception in individuals addicted to narcotic substances in the Farnsworth-Munsell 100-Hue test].
    Nadolska K; Goś R
    Med Pr; 2016 Dec; 67(6):777-785. PubMed ID: 28005086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphofunctional characteristics of the retina and optic nerve in endocrine ophthalmopathy].
    Panteleeva OG; Kuroedov AV; Shamshinova AM; Saakian SV; Romanova EV; Ponomareva EN
    Vestn Oftalmol; 2006; 122(4):25-8. PubMed ID: 16927780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.